To validate the functional significance of this interaction, cell and xenograft mouse experiments were conducted, which demonstrated that disrupting the PTENα-WDR5 interaction by point mutations reduces the expression of downstream oncogenes, inhibiting cell proliferation and tumor growth. The gene discussed is WDR5; the disease is neoplasm.